Xilio Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Xilio Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2024.
  • Xilio Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $400K, a 20% decline year-over-year.
  • Xilio Therapeutics, Inc. annual Depreciation for 2023 was $1.8M, a 5.88% increase from 2022.
  • Xilio Therapeutics, Inc. annual Depreciation for 2022 was $1.7M, a 21.4% increase from 2021.
  • Xilio Therapeutics, Inc. annual Depreciation for 2021 was $1.4M, a 27.3% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $400K -$100K -20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $500K +$100K +25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $400K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $400K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.